Post
RION doses first subject in Phase IIa diabetic foot ulcer therapy trial
Regenerative medicine company RION has dosed the first subject in the Phase IIa clinical trial of its purified exosome product …
LEO Pharma reports positive data from Phase III plaque psoriasis trial
LEO Pharma has announced positive data from the Phase III clinical trial of Enstilar (LEO 90100) in Chinese adult patients …
OCT Europe: Mutual investment a better solution than patient centricity
Making sure that all parties involved in clinical trials are benefitting is more important than adopting a patient-centric approach. Amelia Hursey, …
Psilocybin effective in treating depression
A new study published in the British Medical Journal found potential in the use of psilocybin to treat depression, with …
Mucocort canker sore patch trial approved in native Sweden
Swedish startup Mucocort has received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to commence …
Psilocybin effective in treating depression
A new study published in the British Medical Journal found potential in the use of psilocybin to treat depression, with …
Mucocort canker sore patch trial approved in native Sweden
Swedish startup Mucocort has received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to commence …
OCT Europe: AI and RWD can avoid data replication in trials
AI and real-world data (RWD) can save investigators hours and avoid the need for data replication in clinical trials. Mats Sugden, …
Insmed’s brensocatib: A candidate for bronchiectasis treatment, closer to approval
Insmed has been in the spotlight over the past few years for its pipeline agent, brensocatib, which has previously shown …
Study identifies racial disparities in avoidable hospitalisations in nursing homes
An expanding body of research has shed light on racial disparities in the health outcomes of patients with neurodegenerative diseases. …
AngioDynamics touts positive data from AlphaVac trial
US-based device company AngioDynamics has announced new data that finds its AlphaVac F1885 System safe in patients with acute intermediate-risk …
Researchers hit ‘milestone’ in light therapy for spinal cord injury study
Scientists at the University of Birmingham, UK, have developed a method to repair nerve connections for patients with spinal cord …
VYNE Therapeutics receives FDA approval for trial of VYN202
US-based biopharmaceutical company VYNE Therapeutics has received US Food and Drug Administration clearance for its investigational new drug (IND) application …
Adcentrx receives NMPA approval for solid tumour therapy trial
China’s National Medical Products Administration (NMPA) has approved an investigational new drug (IND) application from Adcentrx Therapeutics to begin a …
GlycoMimetics reports data from Phase III AML treatment trial
US-based biotechnology company GlycoMimetics has released topline results from its Phase III clinical trial of uproleselan, an E-selectin antagonist designed …